Bristol-Myers Squibb: Strong Quality And Attractive Valuation
Tuesday, January 28, 2020 5:50 AM EDT
Bristol-Myers Squibb has an outstanding track record of consistent revenue growth and superior profitability. The stock is very reasonably valued at current levels.